Advertisement
Screener

Coherus Oncology, Inc. (CHRS) Other Non-Current Assets

2.8 / 5 stars · 68/120 Roast Me

Coherus Oncology, Inc. Other Non-Current Assets

Coherus Oncology, Inc. (CHRS) had Other Non-Current Assets of $3.12 million as of 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Balance Sheet › Assets › Assets, Noncurrent

us-gaap:OtherAssetsNoncurrent · last filed 2026-08-05

  • 2026-06-30: Other Assets, Noncurrent $3.12M.
  • 2026-03-31: Other Assets, Noncurrent $3.59M.
  • 2025-12-31: Other Assets, Noncurrent $4.05M.
  • 2025-09-30: Other Assets, Noncurrent $4.45M.
Period endOther Assets, NoncurrentOther Assets, Noncurrent as first filed
2026-06-30$3.12M
10-Q · filed 2026-08-05
2026-03-31$3.59M
10-Q · filed 2026-05-11
2025-12-31$4.05M
10-Q · filed 2026-08-05
2025-09-30$4.45M
10-Q · filed 2025-11-06
2025-06-30$5.04M
10-Q · filed 2025-08-07
2025-03-31$5.66M
10-Q · filed 2025-05-12
2024-12-31$6.49M
10-K · filed 2026-03-09
$6.69M
10-K · filed 2025-03-17
2024-09-30$7.38M
10-Q · filed 2024-11-06
2024-06-30$8.26M
10-Q · filed 2024-08-08
2024-03-31$9.13M
10-Q · filed 2024-05-09
2023-12-31$9.08M
8-K · filed 2025-11-13
$9.69M
10-K · filed 2024-03-15
2023-09-30$7.82M
10-Q · filed 2023-11-06
2023-06-30$7.52M
10-Q · filed 2023-08-02
2023-03-31$7.83M
10-Q · filed 2023-05-08
2022-12-31$8.67M
10-K · filed 2024-03-15
2022-09-30$9.63M
10-Q · filed 2022-11-08
2022-06-30$10.15M
10-Q · filed 2022-08-04
2022-03-31$9.96M
10-Q · filed 2022-05-05
2021-12-31$10.03M
10-K · filed 2023-03-06
2021-09-30$10.26M
10-Q · filed 2021-11-08
2021-06-30$10.42M
10-Q · filed 2021-08-05
2021-03-31$10.74M
10-Q · filed 2021-05-06
2020-12-31$12.54M
10-K · filed 2022-02-23
$2.15M
10-K · filed 2021-02-25
2020-09-30$976.00K
10-Q · filed 2020-11-05
2020-06-30$1.64M
10-Q · filed 2020-08-06
2020-03-31$362.00K
10-Q · filed 2020-05-07
2019-12-31$362.00K
10-K · filed 2021-02-25
2019-09-30$514.00K
10-Q · filed 2019-11-08
2019-06-30$14.00K
10-Q · filed 2019-08-05
2019-03-31$14.00K
10-Q · filed 2019-05-09
2018-12-31$14.00K
10-K · filed 2020-02-27
2018-09-30$14.00K
10-Q · filed 2018-11-08
2018-06-30$14.00K
10-Q · filed 2018-08-08
2018-03-31$14.00K
10-Q · filed 2018-05-10
2017-12-31$13.00K
10-K · filed 2019-02-28
2017-09-30$14.00K
10-Q · filed 2017-11-06
2017-06-30$14.00K
10-Q · filed 2017-08-07
2017-03-31$14.00K
10-Q · filed 2017-05-08
2016-12-31$1.88M
10-K · filed 2018-03-08
2016-09-30$15.00K
10-Q · filed 2016-11-09
2016-06-30$15.00K
10-Q · filed 2016-08-09
2016-03-31$9.00K
10-Q · filed 2016-05-09
2015-12-31$146.00K
10-K · filed 2017-03-14
2015-09-30$10.00K
10-Q · filed 2015-11-10
2015-06-30$50.00K
10-Q · filed 2015-08-10
2015-03-31$589.00K
10-Q · filed 2015-05-11
2014-12-31$50.00K
10-K · filed 2016-02-29
2014-09-30$3.06M
10-Q · filed 2014-12-15
2013-12-31$27.00K
10-K · filed 2015-03-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alpha Cognition Inc. (ACOG)$0.185B-6.77
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Alector, Inc. (ALEC)United States$0.213B-1.90
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37